Australian & New Zealand Childrens Haematology/Oncology Group

Clinical Trials

Viewing: Clinical Trials

Filter by

Brain cancer: Medulloblastoma

Status: Open | NSW , QLD , VIC , WA

SJ ELiOT: Phase 1 Evaluation of LY2606368, a CHK inhibitor, in combination with cyclophosphamide or gemcitabine for children & adolescents with recurrent medulloblastoma tumours.

Brain and solid tumours

Status: Open | NSW , QLD , VIC , WA , SA

COZMOS: Phase I/Ib trial of Combined 5’azacitidine and carboplatin for recurrent/refractory paediatric brain and solid tumours

High risk haematological malignancy, or a non-malignant disease

Status: Open | NSW , QLD , VIC , WA , New Zealand

Pαβlo: Paediatric αβ haploidentical transplantation

High-risk cancers

Status: Open | NSW , QLD , TAS , VIC , WA , SA

PRISM: PRecISion Medicine for Children with Cancer

Leukaemia, solid tumours and brain tumours

Status: Open | NSW , QLD , WA , SA

PARC: An international phase I/II study evaluating the safety and activity of Pegylated recombinant human Arginase (BCT-100) in Relapsed/refractory cancers of Children and young adults.

Leukaemia: AML and High Risk MDS

Status: Open | NSW , QLD , VIC , WA , SA , New Zealand

MyeChild 01: International Randomised Phase III Clinical Trial in Children with Acute Myeloid Leukaemia: Incorporating an Embedded Dose Finding Study for Gemtuzumab Ozogamicin in Combination with Induction Chemotherapy

All posts loaded.

All posts loaded.

Load more trials